Literature DB >> 13304797

Depressive states during Rauwolfia therapy for arterial hypertension; a report of 30 cases.

G LEMIEUX, A DAVIGNON, J GENEST.   

Abstract

Entities:  

Keywords:  DEPRESSION/etiology and pathogenesis; HYPERTENSION/therapy; RAUWOLFIA ALKALOIDS/injurious effects

Mesh：

Substances：

Year:  1956        PMID： 13304797      PMCID： PMC1823144     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  10 in total

1.  Clinical uses of rauwolfia. I. In arterial hypertension.

Authors:  J GENEST; L ADAMKIEWICZ; R ROBILLARD; G TREMBLAY
Journal:  Can Med Assoc J       Date:  1955-04-01       Impact factor: 8.262

2.  Oral preparations of Reuwolfia serpentina in treatment of essential hypertension.

Authors:  S LOCKET
Journal:  Br Med J       Date:  1955-04-02

3.  Treatment of hypertension; hypotensive drugs and mental changes.

Authors:  D C WALLACE
Journal:  Lancet       Date:  1955-07-16       Impact factor: 79.321

4.  Hypertension treated with Rauwolfia serpentina (whole root) and with reserpine; controlled study disclosing occasional severe depression.

Authors:  R W ACHOR; N O HANSON; R W GIFFORD
Journal:  J Am Med Assoc       Date:  1955-10-29

5.  Psychosis apparently produced by reserpine.

Authors:  H A SCHROEDER; H M PERRY
Journal:  J Am Med Assoc       Date:  1955-10-29

6.  Depression and anxiety occurring during Rauwolfia therapy.

Authors:  J C MULLER; W W PRYOR; J E GIBBONS; E S ORGAIN
Journal:  J Am Med Assoc       Date:  1955-10-29

7.  Treatment of hypertension with reserpine, with reserpine in combination with pentapyrrolidinium, and with reserpine in combination with Veratrum alkaloids.

Authors:  A E DOYLE; E G McQUEEN; F H SMIRK
Journal:  Circulation       Date:  1955-02       Impact factor: 29.690

8.  Mental depression in hypertensive patients treated for long periods with large doses of reserpine.

Authors:  E D FREIS
Journal:  N Engl J Med       Date:  1954-12-16       Impact factor: 91.245

9.  Hypotensive action of reserpin.

Authors:  A E DOYLE; F H SMIRK
Journal:  Lancet       Date:  1954-05-29       Impact factor: 79.321

10.  Clinical experience with reserpine (serpasil): a controlled study.

Authors:  H P DUSTAN; R D TAYLOR; A C CORCORAN; I H PAGE
Journal:  Ann N Y Acad Sci       Date:  1954-04-30       Impact factor: 5.691
  10 in total
  21 in total

Review 1.  [Reserpine-diuretic combinations in therapy of arterial hypertension. Current considerations].

Authors:  M Siepmann; W Kirch
Journal:  Med Klin (Munich)       Date:  1998-12-15

2.  Mental depressive episodes during Rauwolfia therapy for arterial hypertension, with special reference to dosage.

Authors:  E BOLTE; J MARC-AURELE; J BROUILLET; P BEAUREGARD; M VERDY; J GENEST
Journal:  Can Med Assoc J       Date:  1959-02-15       Impact factor: 8.262

3.  A clinical and biochemical study of a trial of iproniazid in the treatment of depression.

Authors:  C M PARE; M SANDLER
Journal:  J Neurol Neurosurg Psychiatry       Date:  1959-08       Impact factor: 10.154

4.  Management and concept of human arterial hypertension.

Authors:  J GENEST
Journal:  Can Med Assoc J       Date:  1956-10-15       Impact factor: 8.262

Review 5.  Reserpine: a relic from the past or a neglected drug of the present for achieving cost containment in treating hypertension?

Authors:  G J Magarian
Journal:  J Gen Intern Med       Date:  1991 Nov-Dec       Impact factor: 5.128

Review 6.  Dopamine and disease.

Authors:  A Barbeau
Journal:  Can Med Assoc J       Date:  1970-10-17       Impact factor: 8.262

7.  [Differential treatment of Parkinson's disease, with special reference to the possibility of iatrogenic disorders (author's transl)].

Authors:  W Gehlen
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1974-04-09

8.  Effects of antipsychotic treatment on psychopathology and motor symptoms. A placebo-controlled study in healthy volunteers.

Authors:  Tanja Veselinović; Holger Schorn; Ingo Vernaleken; Katharina Schiffl; Christoph Hiemke; Gerald Zernig; Ruben Gur; Gerhard Gründer
Journal:  Psychopharmacology (Berl)       Date:  2011-06-04       Impact factor: 4.530

Review 9.  Drug-induced psychiatric disorders.

Authors:  D A Johnson
Journal:  Drugs       Date:  1981-07       Impact factor: 9.546

Review 10.  Rauwolfia in the Treatment of Hypertension.

Authors:  Douglas Lobay
Journal:  Integr Med (Encinitas)       Date:  2015-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.